Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
Date:4/24/2008

SAN DIEGO, April 24 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has established a distribution partnership in the Czech market through the Almeda Company, a Prague-based firm specializing in medical device sales in the region for almost two decades.

Michel Vaudry, SpectraScience's Director of International Sales commented that "the Czech Republic is attractive on many fronts as an entry point into the European market for our WavSTAT System, both for its aging population and its established $1.2 billion medical device market. In addition, the Czech Republic has one of the highest incidences of colorectal cancer in the world. We are exploring additions to our export sales team in other European countries such as Italy, Germany and France."

Almeda's Director Ales Zavorka stated that "the WavSTAT System fills a significant gap in our product offering to the Czech market which has a particularly high incidence of colon cancer. Other drivers for the product in the market are its ease of use and performance, both of which are extremely appealing to the physician community."

Key Benefits to the WavSTAT Optical Biopsy System

-- Leaves polyps on site if they are not pre-cancerous

-- Ability for physician to perform physical biopsy at exactly same site

as optical biopsy

-- Aids physician during colon cancer surgery

-- Complementary to NBI and Smart Pill

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-KSB and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-KSB and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA(R) cervical imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.

Contact:

SpectraScience, Inc.

Jim Hitchin, Chief Executive Officer

(858) 847-0200 x201

http://www.spectrascience.com

Hayden Communications

Investor Relations

Todd Pitcher

(858) 518-1387


'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SpectraScience, Inc. Retains Hayden Communications
2. SpectraScience Acquires Luma Imaging Corporation
3. SpectraScience Receives Final European Certification
4. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
5. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Piedmont Pharmaceuticals Secures $8.5 Million Investment
8. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
9. UI licensee Optherion secures $37 million in financing
10. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
11. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... With certifications and experience that puts them at the top of the ... are currently accepting new patients at their practice for these custom clear aligners. These ... is why they offer the latest in modern dental techniques to ensure that all ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage (UA), a multi-channel retailer ... designed to create tailored looks and athleisure-inspired outfits. UA Flex fabric is breathable, wrinkle ... twill. , With trendy looks hitting the medical community, UA Flex is for the ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... bedside, would like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN ... whose insight and expertise in healthcare will provide invaluable direction for the company,” ...
(Date:6/19/2017)... New York, NY (PRWEB) , ... June 19, 2017 , ... ... and this year, it’s going to be a humdinger. A warm winter and wet ... devour summer wedding guests. “No one wants to be swatting away pesky mosquitoes when ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... nonprofit community, announces the general availability of several new and improved features to ... integration with United Way iGuide data in support of national campaigns. The ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the ... Tuesday, June 13, 2017, in Rancho Palos Verdes, ... chief executive officer, is scheduled to present at 3:20 p.m. ... accessed at http://ir.hill-rom.com/events.cfm . A recorded replay will be ... September 13, 2017. ...
(Date:5/29/2017)... May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... which enables the functional selection of stem cells, today ... the first quarter ended March 31 st , 2017. ... accomplishments in the first quarter of 2017," said Dr. ... we announced the treatment of the first blood cancer ...
(Date:5/26/2017)... BARBARA, Calif. , May 25, 2017  In ... United States , Direct Relief is working with ... overdose-reversing Naloxone available at no cost to community health ... other nonprofit providers nationwide. "Pfizer has ... access to medicines and ensuring patient safety through educational ...
Breaking Medicine Technology: